Skip to content

Clinical trials

Phase 1 HIV Infections trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: HIV Infections Phase: Phase 1 Country / region: South Africa Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20051
20062
20072
20081
20092
20102
20112
20131
20141
20152
20161
20172
20181
20201
20213
20222
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Active, not recruiting1
Not yet recruiting1
Suspended1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)10
HIV Vaccine Trials Network6
International Partnership for Microbicides, Inc.3
AlphaVax, Inc.2
ApoPharma2
International AIDS Vaccine Initiative2
Boehringer Ingelheim1
Bristol-Myers Squibb1
Henry M. Jackson Foundation for the Advancement of Military Medicine1
New York State Psychiatric Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
HIV Infections33
Tuberculosis3
Acquired Immunodeficiency Syndrome2
HIV Seropositivity1
Immune System Diseases1
Immunologic Deficiency Syndromes1
Lentivirus Infections1
RNA Virus Infections1
Retroviridae Infections1
Sexually Transmitted Diseases1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.